The short version
- Intraduodenal quinine at 300 mg and 600 mg reduced peak plasma glucose and slowed gastric emptying in men with type 2 diabetes, with the 600 mg dose lowering peak glucose by 2.8 mmol/l.
- In the same study quinine had no effect before food arrived and did not change how much participants ate at a buffet lunch.
- When equally bitter quinine or naringin solutions were infused into the stomach of healthy people, neither slowed gastric emptying compared with water and neither changed hunger or fullness.
- The one bitter-herb preparation with a meta-analysis is STW 5, which beat placebo on the most bothersome symptom of functional dyspepsia with an odds ratio of 0.22 across three pooled trials.
- No published human trial shows that a commercial bitters tincture taken on the tongue before a meal improves digestion or reduces bloating.
The little amber dropper bottle has had a very good few years. Gentian, dandelion, artichoke, wormwood, orange peel — a few drops on the tongue before a meal, and the claim is that you have woken up your digestion.
The mechanism is genuinely interesting, the human evidence for the product is genuinely thin, and those two sentences are not in conflict. Here is where the line falls.
Bitter receptors outside the mouth are real
Bitter taste receptors are not confined to the tongue. They are expressed along the gastrointestinal tract, and activating them there does measurable things.
The cleanest human demonstration comes from a double-blind randomised crossover study in men with type 2 diabetes. Quinine was delivered intraduodenally — through a tube, straight past the mouth and stomach — at 300 mg or 600 mg, thirty minutes before a nutrient drink. Both doses markedly reduced the peak plasma glucose response, with the 600 mg dose lowering it by 2.8 ± 0.6 mmol/l, and both slowed gastric emptying. The 600 mg dose modestly raised GLP-1 and C-peptide.
Two details in that same study matter for anyone holding a dropper bottle. Quinine alone, before the drink arrived, had no effect at all. And it did not change how much people ate at a buffet lunch.
The pharmaceutical industry has noticed. A purified bitter receptor agonist, denatonium acetate, has been through a first-in-human placebo-controlled phase 1 trial in healthy adults. When a mechanism reaches phase 1, it is being treated as a drug target, not a wellness ritual.
Tasting bitter is not the same as delivering bitter
This is the part the category tends to skip. Little and colleagues ran the experiment directly: healthy subjects received 500 ml intragastric infusions of equally bitter solutions of quinine or naringin, or water. Neither bitter tastant slowed gastric emptying compared with water. None of the solutions changed hunger or fullness ratings. Their conclusion was that in humans, the presence of bitterness per se does not appear to signal in a way that influences gastric emptying or appetite.
So: 600 mg of quinine dripped into the duodenum does something measurable. A bitter solution sitting in the stomach did not. A few drops of a tincture on your tongue is a third thing again, and it is the one nobody has run the trial on.
The bitter preparation that does have a meta-analysis
There is one, and it is not sold as bitters. STW 5, known commercially as Iberogast, is a fixed multi-herb preparation containing bitter candytuft, peppermint and chamomile among others. Melzer and colleagues pooled the raw data from three placebo-controlled trials in functional dyspepsia: 138 on the preparation against 135 on placebo, with an odds ratio of 0.22 (95% CI 0.11–0.47, p = 0.001) for the severity of the most bothersome gastrointestinal symptom. A fourth trial found no significant difference against cisapride, a prokinetic drug. Adverse events were similar to placebo.
That is a real result for a specific, standardised, multi-herb product in a specific condition. It is not evidence for bitters as a category, and it is certainly not evidence for whichever combination is in the bottle you are looking at.
The honest summary
What can be said: bitter receptors in the gut exist, they influence gut hormone release and gastric emptying when stimulated properly, and one standardised herbal preparation containing bitter herbs beat placebo in functional dyspepsia.
What cannot be said: that a few drops of a commercial bitters tincture before a meal has been shown to improve digestion, reduce bloating, or increase stomach acid in a human trial. Nobody has published that trial. If a brand tells you the studies are there, ask which ones, and check whether the dose went in through a tube.
What we would tell you
We do not sell bitters, so we have nothing riding on this. They are cheap, food-adjacent, low-risk for most people, and the ritual of pausing before a meal may be doing more than the herbs. If they make dinner more comfortable and cost you almost nothing, that is a fine place to put ten dollars a month. Do not pay premium supplement prices for them, and do not expect them to do a job that has a diagnosis attached.
Two cautions. Alcohol-based tinctures and bitter herbs can aggravate reflux, so if heartburn is your problem this is the wrong direction. And they will not fix the things people usually buy them for: if you are trying to work out what causes bloating in your own case, that is a differential with a list of tests on it, and chronic constipation sits high on it. If a specific food is the trigger, digestive enzymes match a tool to a molecule and bitters do not. If your issue is greasy, pale stools after a gallbladder removal, that is an ox bile conversation, and it is one to have with a doctor first.
Good questions
Do digestive bitters actually work?
There is no human trial of a commercial bitters tincture showing that it improves digestion. The underlying mechanism is real, and 600 mg of quinine delivered through a tube into the duodenum measurably slows gastric emptying. But when bitter solutions were simply infused into the stomach, nothing happened to emptying, hunger or fullness. The gap between those two experiments is where the product sits.
Do bitters increase stomach acid?
That claim is traditional rather than demonstrated. We could not find a human trial measuring gastric acid output after a commercial bitters preparation, and we looked. If low stomach acid is genuinely your problem, it is diagnosable and worth diagnosing rather than treating on the basis of a mechanism nobody has confirmed in people.
Are bitters worth the money?
At a few dollars a month, possibly, for the ritual as much as the herbs. At premium supplement prices, no. We do not sell them, so there is nothing in it for us either way. If a pause and a strong taste before eating makes your meal more comfortable, that is a real experience and a cheap one. It is not a treatment.
Is Iberogast the same as taking bitters?
No. STW 5, sold as Iberogast, is a fixed multi-herb preparation trialled in functional dyspepsia, where pooled data from three placebo-controlled studies gave an odds ratio of 0.22 for the most bothersome symptom. That result belongs to that specific formula at that specific dose. It does not transfer to a different combination of bitter herbs in a different bottle.
Can bitters make reflux worse?
They can. Alcohol-based tinctures and bitter herbs are both plausible aggravators of heartburn, so if reflux is your main symptom this is the wrong shelf. Peppermint, which appears in several digestive preparations, is also a known reflux trigger for some people despite helping other gut symptoms.
Should I take bitters for bloating?
We would not start there. Bloating has a differential that includes constipation, carbohydrate malabsorption, coeliac disease and pelvic floor dysfunction, and the useful first move is working out which one you are in. Bitters have no trial evidence for bloating at all, so buying them for it is spending money to avoid a question.
Sources
- Bitarafan V, Fitzgerald PCE, Rehfeld JF, et al. Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study. Diabetologia, 2025. View study
- Little TJ, Gopinath A, Patel N, et al. Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans. Am J Physiol Regul Integr Comp Physiol, 2009. View study
- Melzer J, Rösch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther, 2004. View study
- First-in-Human Evaluation of Oral Denatonium Acetate (ARD-101), a Potential Bitter Taste Receptor Agonist: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial in Healthy Adults. Clin Pharmacol Drug Dev, 2022. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
